Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
1‐Methyl‐3‐propyl‐7‐butylxanthine, a Novel Biochemical Modulator, Enhances Therapeutic Efficacy of Adriamycin
- Y. Sadzuka, A. Iwazaki, T. Sugiyama, Takayuki Sawanishi, K. Miyamoto
- MedicineJapanese journal of cancer research : Gann
- 1 February 1998
1‐Methyl‐3‐propyl‐7‐butylxanthine (XT‐77), which had the greatest inhibitory effect on adriamycin efflux in vitro among the compounds tested, potentiated adriamicin‐induced antitumor activity by causing an increase of adri amycin concentration in the tumor in vitro.